Skip to content
Governance Register

← US public companies

Bicara Therapeutics Inc.

SEC CIK 2023658 · BCAX · last insider filing 2026-06-10

Directors (from insider filings)

NameCapacity as filedFilings
Powell Michael Director filed 2024 - 2026
RA Capital Healthcare Fund LP Director filed 2024 - 2026
RA Capital Management, LLC Director filed 2024 - 2026
Kolchinsky Peter Director filed 2024 - 2026
Bowden Christopher Director filed 2024 - 2026
Shah Rajeev M. Director filed 2024 - 2026
Haviland Kate Director filed 2024 - 2026
Simson Jake Director filed 2024 - 2026
Robertson Scott M. Director filed 2024 - 2026
RA Capital Nexus Fund III, L.P. Director filed 2024 - 2026
Mazumdar-Shaw Kiran Director filed 2024 - 2026
Mazumdar Claire Director · Chief Executive Officer filed 2024 - 2026
Cohlhepp Ryan Director · President and COO filed 2024 - 2026
Lonberg Nils Director filed 2024 - 2025
Deerfield Private Design Fund V, L.P. Director filed 2024 - 2024
NG Carolyn Director filed 2024 - 2024

Officers (from insider filings)

NameTitle as filedFilings
Hyep Ivan Chief Financial Officer filed 2024 - 2026
Schelman William Chief Medical Officer filed 2026 - 2026
Raben David Chief Medical Officer filed 2024 - 2026
Meisner Lara Chief Legal Officer filed 2024 - 2026

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.